Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) [Phase 3]
A Phase 3 clinical trial evaluating ianalumab added to standard-of-care for systemic lupus erythematosus is currently active but not recruit…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity
A Cairo University-led study is recruiting to evaluate nutritional status in rheumatic diseases and its association with disease activity ac…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating a targeted CD19 or CD19-BCMA CAR-T therapy for autoimmune diseases is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Exploratory Phase 1 clinical trial evaluating YTS109 Cell for relapsed/refractory autoimmune diseases, including systemic lupus erythematosu…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus [Phase 3]
Ongoing Phase 3 study evaluating the long-term safety and tolerability of Cenerimod in adults with systemic lupus erythematosus.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases [Phase 1]
A Phase 1 exploratory study evaluating the safety and feasibility of YTS109 cell therapy for multiple autoimmune diseases, currently recruit…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases [Phase 1]
Phase 1 trial update on YTS109 cell therapy for relapsed/refractory autoimmune diseases, currently recruiting across multiple indications.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Phase 1 clinical study of YTS109 cell therapy for refractory autoimmune diseases is currently recruiting. The trial will evaluate safety and…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 in pediatric relapsed/refractory autoimmune diseases, including SLE and diffuse systemic sclerosi…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus [Phase 1]
Autolus Limited is conducting a Phase 1 trial of Obe-cel for severe, refractory systemic lupus erythematosus in adolescents (UK only) and ad…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase exploratory clinical study evaluating the safety and potential efficacy of an anti-CD19/BCMA U CAR-T cell therapy for relapse…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease [Phase 3]
Phase 3 trial evaluating outcomes after stopping hydroxychloroquine in elderly patients with systemic lupus erythematosus; currently recruit…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus [Phase 1]
Phase 1 trial evaluating CD19 CAR T-cell therapy for refractory systemic lupus erythematosus is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Saphnelo Use in Females of Child-bearing Potential
This clinical trial update indicates the use of Saphnelo (anifrolumab) in females of child-bearing potential for systemic lupus erythematosu…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis [Phase 3]
Phase 3 clinical trial update for Anifrolumab in adults with active proliferative lupus nephritis; the study is currently active but not rec…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases [Phase 2]
This Phase 2 master protocol trial, sponsored by Amgen, is evaluating Inebilizumab and Blinatumomab in autoimmune diseases. It is currently …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice
A treatment-effectiveness study evaluating Anifrolumab for systemic lupus erythematosus in routine clinical practice is currently active but…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus [Phase 3]
A Phase 3 trial to evaluate subcutaneous anifrolumab for systemic lupus erythematosus in immunosuppressant-naïve and biologic-naïve patients…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating CART19, autologous CD19-directed CAR T cells, for systemic lupus erythematosus and lupus nephritis.…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
This clinical trial update notes a study in pediatric systemic lupus erythematosus investigating whether early myocardial dysfunction can id…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) [Phase 2]
Phase 2 clinical trial update for rapcabtagene autoleucel in active, refractory systemic lupus erythematosus and lupus nephritis, currently …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial of TI-0032-III Injection for relapsed and refractory autoimmune diseases is currently recruiting, encompassing seve…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus [Phase 1, Phase 2]
A Phase 1/2 clinical trial sponsored by NHLBI is evaluating nicotinamide riboside, an NAD+ precursor, for effects on immunometabolism and im…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants [Phase 1]
A Phase 1 clinical trial is evaluating the safety, tolerability, and pharmacokinetics/pharmacodynamics of Surovatamig in adult participants …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Rheumatology Patient Registry and Biorepository
This Clinical Trial Update describes a Yale University-led rheumatology patient registry and biorepository that is currently recruiting to c…